Dan Du

3.1k total citations · 1 hit paper
103 papers, 2.2k citations indexed

About

Dan Du is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Dan Du has authored 103 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 30 papers in Surgery and 17 papers in Cancer Research. Recurrent topics in Dan Du's work include Pancreatitis Pathology and Treatment (23 papers), Natural product bioactivities and synthesis (9 papers) and Circular RNAs in diseases (7 papers). Dan Du is often cited by papers focused on Pancreatitis Pathology and Treatment (23 papers), Natural product bioactivities and synthesis (9 papers) and Circular RNAs in diseases (7 papers). Dan Du collaborates with scholars based in China, United Kingdom and United States. Dan Du's co-authors include Meng Gong, Yu Hao, Junbing Huang, Jing Qu, Qing Xia, Shuang‐Gang Ma, Shisheng Wang, Shi‐Shan Yu, Yaohui Chen and Wen Zheng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Circulation Research and Analytical Chemistry.

In The Last Decade

Dan Du

96 papers receiving 2.1k citations

Hit Papers

Targeting Mitochondria-Inflammation Circuit by β-Hydroxyb... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Du China 26 935 369 203 196 182 103 2.2k
Shiliang Li China 27 1.3k 1.4× 286 0.8× 164 0.8× 269 1.4× 149 0.8× 126 2.8k
Hua Zhou China 30 1.2k 1.2× 215 0.6× 235 1.2× 164 0.8× 215 1.2× 184 2.9k
Chunyan Hu China 34 1.2k 1.3× 349 0.9× 257 1.3× 456 2.3× 196 1.1× 167 3.1k
Mengyang Liu China 28 793 0.8× 233 0.6× 92 0.5× 137 0.7× 424 2.3× 107 2.2k
Raja Chakraborty India 25 1.1k 1.1× 175 0.5× 167 0.8× 229 1.2× 149 0.8× 86 3.5k
Meng Xu China 24 432 0.5× 262 0.7× 180 0.9× 67 0.3× 149 0.8× 109 1.8k
Xiaoling Cai China 27 697 0.7× 439 1.2× 176 0.9× 94 0.5× 309 1.7× 185 2.7k
Pengli Zhu China 15 684 0.7× 137 0.4× 123 0.6× 213 1.1× 165 0.9× 62 1.5k
Lu Shen China 24 976 1.0× 142 0.4× 186 0.9× 343 1.8× 153 0.8× 106 2.3k
Camelia S. Stancu Romania 21 649 0.7× 568 1.5× 269 1.3× 418 2.1× 234 1.3× 58 2.0k

Countries citing papers authored by Dan Du

Since Specialization
Citations

This map shows the geographic impact of Dan Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Du more than expected).

Fields of papers citing papers by Dan Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Du. The network helps show where Dan Du may publish in the future.

Co-authorship network of co-authors of Dan Du

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Du. A scholar is included among the top collaborators of Dan Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Du. Dan Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
He, Jing, Dan Du, Xue Wang, et al.. (2025). Deciphering the secret codes in N7‐methylguanosine modification: Context‐dependent function of methyltransferase‐like 1 in human diseases. Clinical and Translational Medicine. 15(2). e70240–e70240. 3 indexed citations
3.
Qiu, Qi, Fei Fu, Chenxia Han, et al.. (2024). Rhei Radix et Rhizoma and its anthraquinone derivatives: Potential candidates for pancreatitis treatment. Phytomedicine. 129. 155708–155708. 3 indexed citations
4.
Wang, Yizhuo, Peng Lou, Shuyun Liu, et al.. (2024). Nutrient availability regulates the secretion and function of immune cell–derived extracellular vesicles through metabolic rewiring. Science Advances. 10(7). eadj1290–eadj1290. 14 indexed citations
5.
Wu, Tian, Shuyun Liu, Peng Lou, et al.. (2024). Disease-derived circulating extracellular vesicle preconditioning: A promising strategy for precision mesenchymal stem cell therapy. Acta Pharmaceutica Sinica B. 14(10). 4526–4543. 5 indexed citations
6.
Zhou, Mingxia, Jing He, Yingxia Li, et al.. (2023). N6-methyladenosine modification of REG1α facilitates colorectal cancer progression via β-catenin/MYC/LDHA axis mediated glycolytic reprogramming. Cell Death and Disease. 14(8). 557–557. 24 indexed citations
7.
Gao, Li, Ying Lü, Hai‐Ning Chen, et al.. (2023). Deciphering the Clinical Significance and Kinase Functions of GSK3α in Colon Cancer by Proteomics and Phosphoproteomics. Molecular & Cellular Proteomics. 22(5). 100545–100545. 5 indexed citations
8.
Zhou, Mingxia, Dan Du, Chang Wang, et al.. (2023). EIF4A3-mediated circ_0042881 activates the RAS pathway via miR-217/SOS1 axis to facilitate breast cancer progression. Cell Death and Disease. 14(8). 559–559. 18 indexed citations
9.
Huang, Yan, Na Jiang, Rui Wang, et al.. (2023). Time-Course Lipidomics of Ornithine-Induced Severe Acute Pancreatitis Model Reveals the Free Fatty Acids Centered Lipids Dysregulation Characteristics. Metabolites. 13(9). 993–993. 3 indexed citations
11.
Cai, Wenhao, Jingyu Yang, Xianghui Fu, et al.. (2021). Targeting Macrophage Migration Inhibitory Factor in Acute Pancreatitis and Pancreatic Cancer. Frontiers in Pharmacology. 12. 638950–638950. 28 indexed citations
12.
Peng, Yang, Jiwon Hong, Daniel Raftery, Qing Xia, & Dan Du. (2021). Metabolomic-based clinical studies and murine models for acute pancreatitis disease: A review. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1867(7). 166123–166123. 24 indexed citations
14.
Lin, Yin, et al.. (2020). Effect of intervention model based on BCW theory on self-management behavior and health literacy of patients after PCI. Zhonghua xiandai huli zazhi. 26(2). 256–260. 1 indexed citations
15.
Deng, Yan, Maodi Xie, Qian Li, et al.. (2020). Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF. Circulation Research. 128(2). 232–245. 300 indexed citations breakdown →
17.
Zhou, Yijie, Dan Du, Shuyun Liu, et al.. (2018). Polyacetylene glycoside attenuates ischemic kidney injury by co-inhibiting inflammation, mitochondria dysfunction and lipotoxicity. Life Sciences. 204. 55–64. 21 indexed citations
18.
Yao, Linbo, Chun‐Ru Cheng, Xinmin Yang, et al.. (2018). Ethyl pyruvate and analogs as potential treatments for acute pancreatitis: A review of in vitro and in vivo studies. Pancreatology. 19(2). 209–216. 11 indexed citations
20.
Du, Dan, et al.. (2012). Research on the Relationship between Top Manager Characteristics and Corporate Performance: Based on Comparison between State-owned and Non-State-Owned Listed Companies. Science of Science and Management of S.& T. 33(1). 166–172. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026